Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GHSR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACSM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TSPAN9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLR10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MDM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARVA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMKLR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on